This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peyton, C. L.
Right arrow Articles by Wheeler, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peyton, C. L.
Right arrow Articles by Wheeler, C. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 1998, p. 3248-3254, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies

C. L. Peyton,1 M. Schiffman,2 A. T. Lörincz,3 W. C. Hunt,1 I. Mielzynska,3 C. Bratti,4 S. Eaton,1 A. Hildesheim,2 L. A. Morera,4 A. C. Rodriguez,4 R. Herrero,4,dagger M. E. Sherman,5 and C. M. Wheeler1,*

Department of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, New Mexico1; Epidemiology and Biostatistics Program, National Cancer Institute, Bethesda,2 Digene Corporation, Silver Spring,3 and Johns Hopkins Medical Institutions, Baltimore,5 Maryland; and Caja Costarricense de Seguro Social, San Jose, Costa Rica4

Received 30 April 1998/Returned for modification 12 June 1998/Accepted 4 August 1998

This study compared the performances of three human papillomavirus (HPV) detection tests with specimens collected by three alternative procedures. The HPV tests included the Hybrid Capture Tube test (HCT), the microplate-based Hybrid Capture II test (HC II), and the MY09-MY11 L1 consensus primer PCR-based assay. Initial cervical specimens were collected from study subjects with a broom device, and after Papanicolaou smears were made, residual specimens were placed into PreservCyt (PC), a liquid cytology medium. A second specimen was collected from each subject and placed into Digene Specimen Transport Medium (STM). The device for collection of the second specimen alternated with consecutive subjects between a conical cytology brush and a Dacron swab. At the 1.0-pg/ml cutoff, the results of the HC II agreed well with those of the PCR. Specifically, when PCR data were restricted to the types found by the HC II (HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68), there was greater than 90% agreement between the HC II and PCR results with both STM and PC. At a lower cutoff (0.2 pg/ml), HC II-positive results increased further, especially when the test was applied to the PC specimens. However, false-positive HC II results were more often observed at the 0.2-pg/ml cutoff. HC II yielded the highest HPV positivity with specimens placed into PC, followed by specimens collected with a conical brush and placed into STM and, last, by those collected with a Dacron swab and placed into STM. Our results demonstrate the utility of both the STM and PC specimen collection methods and show good agreement between the HC II and PCR.

* Corresponding author. Mailing address: University of New Mexico, School of Medicine, Department of Molecular Genetics and Microbiology, 915 Camino de Salud NE, Albuquerque, NM 87131-5276. Phone: (505) 272-9151. Fax: (505) 277-5273. E-mail: cwheeler{at}salud.unm.edu.

dagger Present address: International Agency for Research against Cancer, Lyon, France.

Journal of Clinical Microbiology, November 1998, p. 3248-3254, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Poljak, M., Kocjan, B. J., Kovanda, A., Lunar, M. M., Lepej, S. Z., Planinic, A., Seme, K., Vince, A. (2009). Human Papillomavirus Genotype Specificity of Hybrid Capture 2 Low-Risk Probe Cocktail. J. Clin. Microbiol. 47: 2611-2615 [Abstract] [Full Text]  
  • Castle, P. E., Solomon, D., Wheeler, C. M., Gravitt, P. E., Wacholder, S., Schiffman, M. (2008). Human Papillomavirus Genotype Specificity of Hybrid Capture 2. J. Clin. Microbiol. 46: 2595-2604 [Abstract] [Full Text]  
  • Safaeian, M, Kiddugavu, M, Gravitt, P E, Gange, S J, Ssekasanvu, J, Murokora, D, Sklar, M, Serwadda, D, Wawer, M J, Shah, K V, Gray, R (2008). Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda. Sex. Transm. Infect. 84: 306-311 [Abstract] [Full Text]  
  • Boulet, G. A.V., Horvath, C. A.J., Berghmans, S., Bogers, J. (2008). Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker. Cancer Epidemiol. Biomarkers Prev. 17: 810-817 [Abstract] [Full Text]  
  • Ogunmodede, F., Yale, S. H., Krawisz, B., Tyler, G. C., Evans, A. C. (2007). Human Papillomavirus Infections in Primary Care. Clin Med Res 5: 210-217 [Abstract] [Full Text]  
  • Stevens, M. P., Garland, S. M., Rudland, E., Tan, J., Quinn, M. A., Tabrizi, S. N. (2007). Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results. J. Clin. Microbiol. 45: 2130-2137 [Abstract] [Full Text]  
  • Safaeian, M., Herrero, R., Hildesheim, A., Quint, W., Freer, E., Van Doorn, L.-J., Porras, C., Silva, S., Gonzalez, P., Bratti, M. C., Rodriguez, A. C., Castle, P., for the Costa Rican Vaccine Trial Group, (2007). Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica. J. Clin. Microbiol. 45: 1447-1454 [Abstract] [Full Text]  
  • Carozzi, F., Bisanzi, S., Sani, C., Zappa, M., Cecchini, S., Ciatto, S., Confortini, M. (2007). Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay in Detection of High-Risk Human Papillomavirus and Diagnosis of Biopsy-Confirmed High-Grade Cervical Disease. J. Clin. Microbiol. 45: 364-369 [Abstract] [Full Text]  
  • Halfon, P., Trepo, E., Antoniotti, G., Bernot, C., Cart-Lamy, P., Khiri, H., Thibaud, D., Marron, J., Martineau, A., Penaranda, G., Benmoura, D., Blanc, B., and RBML (Reseau de Biologie Moleculaire Liberale), (2007). Prospective Evaluation of the Hybrid Capture 2 and AMPLICOR Human Papillomavirus (HPV) Tests for Detection of 13 High-Risk HPV Genotypes in Atypical Squamous Cells of Uncertain Significance. J. Clin. Microbiol. 45: 313-316 [Abstract] [Full Text]  
  • Kreimer, A. R., Katki, H. A., Schiffman, M., Wheeler, C. M., Castle, P. E., for the ASCUS-LSIL Triage Study Group, (2007). Viral Determinants of Human Papillomavirus Persistence following Loop Electrical Excision Procedure Treatment for Cervical Intraepithelial Neoplasia Grade 2 or 3. Cancer Epidemiol. Biomarkers Prev. 16: 11-16 [Abstract] [Full Text]  
  • Han, J., Swan, D. C., Smith, S. J., Lum, S. H., Sefers, S. E., Unger, E. R., Tang, Y.-W. (2006). Simultaneous Amplification and Identification of 25 Human Papillomavirus Types with Templex Technology. J. Clin. Microbiol. 44: 4157-4162 [Abstract] [Full Text]  
  • Kovacic, M. B., Castle, P. E., Herrero, R., Schiffman, M., Sherman, M. E., Wacholder, S., Rodriguez, A. C., Hutchinson, M. L., Bratti, M. C., Hildesheim, A., Morales, J., Alfaro, M., Burk, R. D. (2006). Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.. Cancer Res. 66: 10112-10119 [Abstract] [Full Text]  
  • Sandri, M. T., Lentati, P., Benini, E., Dell'Orto, P., Zorzino, L., Carozzi, F. M., Maisonneuve, P., Passerini, R., Salvatici, M., Casadio, C., Boveri, S., Sideri, M. (2006). Comparison of the Digene HC2 Assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for Detection of High-Risk HPV Genotypes in Cervical Samples.. J. Clin. Microbiol. 44: 2141-2146 [Abstract] [Full Text]  
  • Kreimer, A. R., Guido, R. S., Solomon, D., Schiffman, M., Wacholder, S., Jeronimo, J., Wheeler, C. M., Castle, P. E., for the ASCUS-LSIL Triage Study (ALTS) Group, (2006). Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.. Cancer Epidemiol. Biomarkers Prev. 15: 908-914 [Abstract] [Full Text]  
  • Huang, S.-L., Chao, A., Hsueh, S., Chao, F.-Y., Huang, C.-C., Yang, J.-E., Lin, C.-Y., Yan, C.-C., Chou, H.-H., Huang, K.-G., Huang, H.-J., Wu, T.-I, Tseng, M.-J., Qiu, J.-T., Lin, C.-T., Chang, T.-C., Lai, C.-H. (2006). Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-Based Assay for Detection of Human Papillomavirus DNA in Cervical Swab Samples.. J. Clin. Microbiol. 44: 1733-1739 [Abstract] [Full Text]  
  • Soderlund-Strand, A., Rymark, P., Andersson, P., Dillner, J., Dillner, L. (2005). Comparison between the Hybrid Capture II Test and a PCR-Based Human Papillomavirus Detection Method for Diagnosis and Posttreatment Follow-Up of Cervical Intraepithelial Neoplasia. J. Clin. Microbiol. 43: 3260-3266 [Abstract] [Full Text]  
  • Kulmala, S.-M., Syrjanen, S., Shabalova, I., Petrovichev, N., Kozachenko, V., Podistov, J., Ivanchenko, O., Zakharenko, S., Nerovjna, R., Kljukina, L., Branovskaja, M., Grunberga, V., Juschenko, A., Tosi, P., Santopietro, R., Syrjanen, K. (2004). Human Papillomavirus Testing with the Hybrid Capture 2 Assay and PCR as Screening Tools. J. Clin. Microbiol. 42: 2470-2475 [Abstract] [Full Text]  
  • Flores-Munguia, R., Siegel, E., Klimecki, W. T., Giuliano, A. R. (2004). Performance Assessment of Eight High-Throughput PCR Assays for Viral Load Quantitation of Oncogenic HPV Types. J. Mol. Diagn. 6: 115-124 [Abstract] [Full Text]  
  • Castle, P. E., Lorincz, A. T., Scott, D. R., Sherman, M. E., Glass, A. G., Rush, B. B., Wacholder, S., Burk, R. D., Manos, M. M., Schussler, J. E., Macomber, P., Schiffman, M. (2003). Comparison between Prototype Hybrid Capture 3 and Hybrid Capture 2 Human Papillomavirus DNA Assays for Detection of High-Grade Cervical Intraepithelial Neoplasia and Cancer. J. Clin. Microbiol. 41: 4022-4030 [Abstract] [Full Text]  
  • Coker, A. L., Bond, S., Madeleine, M. M., Luchok, K., Pirisi, L. (2003). Psychosocial Stress and Cervical Neoplasia Risk. Psychosom. Med. 65: 644-651 [Abstract] [Full Text]  
  • Iftner, T., Villa, L. L. (2003). Chapter 12: Human Papillomavirus Technologies. J Natl Cancer Inst Monogr 2003: 80-88 [Abstract] [Full Text]  
  • Kornegay, J. R., Roger, M., Davies, P. O., Shepard, A. P., Guerrero, N. A., Lloveras, B., Evans, D., Coutlee, F. (2003). International Proficiency Study of a Consensus L1 PCR Assay for the Detection and Typing of Human Papillomavirus DNA: Evaluation of Accuracy and Intralaboratory and Interlaboratory Agreement. J. Clin. Microbiol. 41: 1080-1086 [Abstract] [Full Text]  
  • Castle, P. E., Schiffman, M., Burk, R. D., Wacholder, S., Hildesheim, A., Herrero, R., Bratti, M. C., Sherman, M. E., Lorincz, A. (2002). Restricted Cross-Reactivity of Hybrid Capture 2 with Nononcogenic Human Papillomavirus Types. Cancer Epidemiol. Biomarkers Prev. 11: 1394-1399 [Abstract] [Full Text]  
  • Kulasingam, S. L., Hughes, J. P., Kiviat, N. B., Mao, C., Weiss, N. S., Kuypers, J. M., Koutsky, L. A. (2002). Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical Abnormalities: Comparison of Sensitivity, Specificity, and Frequency of Referral. JAMA 288: 1749-1757 [Abstract] [Full Text]  
  • Castle, P. E., Wacholder, S., Lorincz, A. T., Scott, D. R., Sherman, M. E., Glass, A. G., Rush, B. B., Schussler, J. E., Schiffman, M. (2002). A Prospective Study of High-Grade Cervical Neoplasia Risk Among Human Papillomavirus-Infected Women. JNCI J Natl Cancer Inst 94: 1406-1414 [Abstract] [Full Text]  
  • Mandelblatt, J. S., Lawrence, W. F., Womack, S. M., Jacobson, D., Yi, B., Hwang, Y.-t., Gold, K., Barter, J., Shah, K. (2002). Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer. JAMA 287: 2372-2381 [Abstract] [Full Text]  
  • Klencke, B., Matijevic, M., Urban, R. G., Lathey, J. L., Hedley, M. L., Berry, M., Thatcher, J., Weinberg, V., Wilson, J., Darragh, T., Jay, N., Da Costa, M., Palefsky, J. M. (2002). Encapsulated Plasmid DNA Treatment for Human Papillomavirus 16-associated Anal Dysplasia: A Phase I Study of ZYC101. Clin. Cancer Res. 8: 1028-1037 [Abstract] [Full Text]  
  • Szuhai, K., Sandhaus, E., Kolkman-Uljee, S. M., Lemaitre, M., Truffert, J.-C., Dirks, R. W., Tanke, H. J., Fleuren, G. J., Schuuring, E., Raap, A. K. (2001). A Novel Strategy for Human Papillomavirus Detection and Genotyping with SybrGreen and Molecular Beacon Polymerase Chain Reaction. Am. J. Pathol. 159: 1651-1660 [Abstract] [Full Text]  
  • Schiff, M., Miller, J., Masuk, M., van Asselt King, L., Altobelli, K. K, Wheeler, C. M, Becker, T. M (2000). Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women. Int J Epidemiol 29: 983-990 [Abstract] [Full Text]  
  • Schiff, M., Becker, T. M., Masuk, M., Asselt-King, L. v., Wheeler, C. M., Altobelli, K. K., North, C. Q., Nahmias, A. J. (2000). Risk Factors for Cervical Intraepithelial Neoplasia in Southwestern American Indian Women. Am J Epidemiol 152: 716-726 [Abstract] [Full Text]  
  • Lytwyn, A., Sellors, J. W., Mahony, J. B., Daya, D., Chapman, W., Ellis, N., Roth, P., Lorincz, A. T., Gafni, A., The HPV Effectiveness in Lowgrade Paps Study No., (2000). Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. CMAJ 163: 701-707 [Abstract] [Full Text]  
  • (ALTS) Group, T. A. S. C. o. U. S./L.-G. S. I. L. T. S. (2000). Human Papillomavirus Testing for Triage of Women With Cytologic Evidence of Low-Grade Squamous Intraepithelial Lesions: Baseline Data From a Randomized Trial. JNCI J Natl Cancer Inst 92: 397-402 [Abstract] [Full Text]  
  • Vernon, S. D., Unger, E. R., Williams, D. (2000). Comparison of Human Papillomavirus Detection and Typing by Cycle Sequencing, Line Blotting, and Hybrid Capture. J. Clin. Microbiol. 38: 651-655 [Abstract] [Full Text]  
  • Schiffman, M., Herrero, R., Hildesheim, A., Sherman, M. E., Bratti, M., Wacholder, S., Alfaro, M., Hutchinson, M., Morales, J., Greenberg, M. D., Lorincz, A. T. (2000). HPV DNA Testing in Cervical Cancer Screening: Results From Women in a High-Risk Province of Costa Rica. JAMA 283: 87-93 [Abstract] [Full Text]  
  • Kónya, J., Veress, G., Juhász, A., Szarka, K., Sápy, T., Hernádi, Z., Gergely, L. (2000). Additional Human Papillomavirus Types Detected by the Hybrid Capture Tube Test among Samples from Women with Cytological and Colposcopical Atypia. J. Clin. Microbiol. 38: 408-411 [Abstract] [Full Text]  
  • Lacey, J. V. Jr., Brinton, L. A., Abbas, F. M., Barnes, W. A., Gravitt, P. E., Greenberg, M. D., Greene, S. M., Hadjimichael, O. C., McGowan, L., Mortel, R., Schwartz, P. E., Silverberg, S. G., Hildesheim, A. (1999). Oral Contraceptives as Risk Factors for Cervical Adenocarcinomas and Squamous Cell Carcinomas. Cancer Epidemiol. Biomarkers Prev. 8: 1079-1085 [Abstract] [Full Text]  
  • Cox, J. T. (1999). Evaluating the Role of HPV Testing for Women With Equivocal Papanicolaou Test Findings. JAMA 281: 1645-1647 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»